Navigation Links
Schering-Plough Announces Results of the Early ACS Trial
Date:3/30/2009

p>

No statistical difference was observed between the groups in either the primary or secondary endpoints. The primary endpoint occurred in 9.3 percent of the study group (receiving double-bolus plus infusion early administration of eptifibatide 12 or more hours prior to angiography), compared with 10.0 percent of the delayed provisional group (p=0.23). At 30 days, the death or (re)MI rate for the study group was 11.2 percent compared to 12.3 percent for the delayed provisional group (p=0.079).

Significantly higher rates of bleeding were observed in the study group, with 118 patients experiencing a TIMI major bleeding event, compared to 83 in the delayed provisional group (p=0.015). Investigators reported a 7.6 percent vs. 5.1 percent rate of moderate or severe bleeding (p<0.001) in the study group as compared to the delayed provisional group, as measured by the GUSTO scale. Red blood cell transfusions occurred in 8.6 percent of patients in the study group vs. 6.7 percent of patients in the delayed provisional group (p=0.001). There were no significant differences in mortality or any serious adverse events between the two groups.

"This was a very well-treated population that demonstrates the influence of aggressive and sophisticated therapies," said Dr. Newby. "Further evaluation of the safety and efficacy data at one year should provide additional insights into the early use of eptifibatide in this patient population."

Within the trial, the single largest group was PCI patients (n=5,559). An analysis of those randomized to receive early eptifibatide showed that these patients experienced fewer primary and secondary composite events after PCI than those randomized to the delayed provisional eptifibatide strategy.

"Consistent with findings from prior trials, in this double-bolus study, NSTE ACS patients undergoing PCI experienced fewer post-PCI ischemic complications with early eptifibat
'/>"/>

SOURCE Schering-Plough
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
2. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
3. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
4. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
5. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
6. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
7. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
8. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
9. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 RnRMarketResearch.com adds Corneal ... report to its store. This report p provides ... The report "Corneal Ulcers - Pipeline Review, H2 ... for Corneal Ulcers. Corneal Ulcers are primarily result ... viral infections & fungal infections. The symptoms of ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the ... The psychological and physical side effects of pain ... opioid painkillers, such as Vicodin and Oxycontin, are safer ... Americans overdose on prescription painkillers than on heroin and ... and CEO of NSC. "Yet, these medications are marketed ...
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ) today announced the ... of the supplemental new drug application (sNDA) for the use ... acute liver failure. The review has been extended by three ... (PDUFA) goal date in December 2010. "We ...
... 20 The European Patent Office ("EPO") Board ... to uphold European Patent No. EP 1307131 for ... http://photos.prnewswire.com/prnh/20061011/SFW044LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO ... 26th, keeps the GlideScope patent in force in ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3European Patent Office Upholds GlideScope® Video Laryngoscope Patent 2
(Date:3/1/2015)... 01, 2015 Researchers say working around ... many sheet metal workers contract malignant mesothelioma. Surviving Mesothelioma ... on its website. Click here to read it ... Research and Training monitored 17,345 sheet metal workers from ... of them died of mesothelioma or another asbestos-related ...
(Date:3/1/2015)... Indianapolis, Indiana (PRWEB) March 01, 2015 ... Indiana statewide Network Service Provider, announces NewWays Networking, ... provider. “By working with IFN, NewWays is ... to meet client’s demand for Internet bandwidth in ... Owner/Manager. , According to Cory Childs IFN ...
(Date:3/1/2015)... CrossFit Attollo is a CrossFit gym located in Vancouver ... to new members. Now through the end of March ... will receive their fourth month half off. , ... The three month contract is only $264, dropping the price ... comes in at only $55. The special saves new members ...
(Date:2/28/2015)... In a recent episode of SCI TV ... Athlete Development Services and Consultancy talks with Joshua ... development and player engagement during and after their careers. ... face and how off-field activities are a critical component ... in athlete development issues while in graduate school coaching ...
(Date:2/28/2015)... 2015 The Classic Denture Center ... new special. Throughout all of March patients can ... This service can help overall mouth health ... Patients may notice certain symptoms that suggest the denture ... symptoms include: , 1.    Pain, clicking, and popping in the ...
Breaking Medicine News(10 mins):Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2
... Corresponding Journal of Nutrition supplement urges health professionals to ... to be published in the June issue of the ... and the general public to stop demonizing high fructose ... rethink the myths about high fructose corn syrup,s impact ...
... NAS to Store Public Database of Genomic and Trait Data ... Isilon(R) Systems (Nasdaq: ISLN ), the ... Personal Genome Project (PGP) has deployed Isilon ... for an unprecedented research project aimed at transforming the use ...
... Keeping Up on Developments in the Long term Care Insurance ... interest in long term care insurance need no longer dig ... pros do: have the information come to them, in bits ... secrets," says Jonas Roeser, Senior Vice President of Marketing & ...
... on lung cancer and mesothelioma specialists into one of ... asbestos-related diseases. Our searchable, easy-to-use database contains doctor profiles ... it easy for residents of California or New York, ... in their area. , ...
... medical malpractice challenge by introducing low tech solution ... introduces standardized shift reporting and note taking to ... to day tasks.RNReport Card is more efficient by ... It fits conveniently in the pocket of your ...
... Packard Children,s Hospital and the Stanford University School of ... deadly and mysterious bowel disease that strikes medically fragile ... understanding of the disease and its medical management, and ... major killer of children and young adults. , The ...
Cached Medicine News:Health News:Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop 2Health News:Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop 3Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 2Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 3Health News:Long Term Care Alerting Methods Revealed by Industry Leaders 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 3Health News:RN Sisters Bring Low-Tech Innovations to New Nurses and Nursing Students 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 3
14mm from Mid-Screw to Tip, Slightly Curved, Sharp Tips; overall length 110mm; Stainless Steel....
9mm Curved Blades with Sharp Pointed Tips; overall length 90mm; Stainless Steel....
4 Gently Curved, Prongs, 5mm Extended, Stainless Steel Tip; with Titanium Handle....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Medicine Products: